Shanghai Kinetic Medical Co (300326) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Kinetic Medical Co (300326) has a cash flow conversion efficiency ratio of 0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥73.22 Million ≈ $10.71 Million USD) by net assets (CN¥2.88 Billion ≈ $421.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Kinetic Medical Co market cap and net worth for the company's overall valuation and market capitalisation.
Shanghai Kinetic Medical Co - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Shanghai Kinetic Medical Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Kinetic Medical Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Kinetic Medical Co ranked by their cash flow conversion efficiency. Explore 300326 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Hirisun Technology Inc
SHE:300277
|
0.060x |
|
New Trend International Logis-Tech Co Ltd
SHE:300532
|
0.073x |
|
Henan Huaying Agricultural Development Co Ltd
SHE:002321
|
0.036x |
|
Arizona Sonoran Copper Company Inc
TO:ASCU
|
-0.001x |
|
Cosonic Intelligent Tech Co Ltd
SHE:300793
|
-0.026x |
|
China Chippacking Technology Co. Ltd. A
SHG:688216
|
N/A |
|
Hanwha Investment&Securities Co Ltd
KO:003530
|
0.106x |
|
ZJAMP Group Co Ltd
SHE:002758
|
0.072x |
Annual Cash Flow Conversion Efficiency for Shanghai Kinetic Medical Co (2008–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Kinetic Medical Co from 2008 to 2024. View Shanghai Kinetic Medical Co (300326) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.82 Billion ≈ $412.49 Million |
CN¥157.75 Million ≈ $23.08 Million |
0.056x | -39.83% |
| 2023-12-31 | CN¥2.95 Billion ≈ $431.48 Million |
CN¥274.26 Million ≈ $40.13 Million |
0.093x | +10.58% |
| 2022-12-31 | CN¥2.81 Billion ≈ $411.88 Million |
CN¥236.76 Million ≈ $34.64 Million |
0.084x | -38.20% |
| 2021-12-31 | CN¥2.78 Billion ≈ $406.56 Million |
CN¥378.16 Million ≈ $55.34 Million |
0.136x | +28.37% |
| 2020-12-31 | CN¥2.69 Billion ≈ $393.24 Million |
CN¥284.92 Million ≈ $41.69 Million |
0.106x | +14.15% |
| 2019-12-31 | CN¥2.75 Billion ≈ $402.71 Million |
CN¥255.61 Million ≈ $37.40 Million |
0.093x | +143.98% |
| 2018-12-31 | CN¥2.50 Billion ≈ $366.14 Million |
CN¥95.25 Million ≈ $13.94 Million |
0.038x | -47.10% |
| 2017-12-31 | CN¥2.04 Billion ≈ $298.76 Million |
CN¥146.93 Million ≈ $21.50 Million |
0.072x | +1.66% |
| 2016-12-31 | CN¥1.84 Billion ≈ $269.44 Million |
CN¥130.35 Million ≈ $19.07 Million |
0.071x | -16.15% |
| 2015-12-31 | CN¥1.32 Billion ≈ $192.65 Million |
CN¥111.16 Million ≈ $16.27 Million |
0.084x | +29.38% |
| 2014-12-31 | CN¥1.10 Billion ≈ $160.24 Million |
CN¥71.46 Million ≈ $10.46 Million |
0.065x | +0.45% |
| 2013-12-31 | CN¥508.97 Million ≈ $74.48 Million |
CN¥33.07 Million ≈ $4.84 Million |
0.065x | -43.89% |
| 2012-12-31 | CN¥444.92 Million ≈ $65.11 Million |
CN¥51.52 Million ≈ $7.54 Million |
0.116x | -71.25% |
| 2011-12-31 | CN¥93.93 Million ≈ $13.75 Million |
CN¥37.83 Million ≈ $5.54 Million |
0.403x | -2.30% |
| 2010-12-31 | CN¥76.80 Million ≈ $11.24 Million |
CN¥31.66 Million ≈ $4.63 Million |
0.412x | -12.35% |
| 2009-12-31 | CN¥39.10 Million ≈ $5.72 Million |
CN¥18.39 Million ≈ $2.69 Million |
0.470x | -47.45% |
| 2008-12-31 | CN¥16.30 Million ≈ $2.38 Million |
CN¥14.59 Million ≈ $2.13 Million |
0.895x | -- |
About Shanghai Kinetic Medical Co
Shanghai Kinetic Medical Co., Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of medical devices in China and internationally. The company offers invasive spinal, invasive vertebroplasty, radiofrequency ablation, orthopedic trauma implant equipment, artificial organs, orthopedic surgical instruments, and other medical products, as well as surgica… Read more